HIT M&A numbers up despite market downturn
Comments
The reality is that the HIT market is in a turmoil. Medical Economics recently stated in an article how "strong" EHR companies seem to be, yet if you look at their stock prices, they have performed much worse than the IT industry in general (see my last note on this page http://www.emrupdate.com/forums/t/13444.aspx?PageIndex=1 for the market report from the 4/2008 Health Data Management magazine). A big discussion where I ended up sending 3 letters to the editor to ME listing the list of troubled CCHIT-certified EHRs begins on that URL above. Some EMR companies have had their stock valuations decrease almost as much as Bear Stearns. The GE downfall on Friday is interesting, but unfortunately it's difficult to measure the full effect of the EHR market on that particular stock performance. All I could find in my research is that the "healthcare sector" went down 17%, but that includes radiology devices and other hardware related endeavors.
Post new comment
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies





